PR91661

VANCOUVER, BC, Sept. 17, 2021 /PRNewswire=KYODO JBN/ --

- Advanced real-time clinical diagnostics for up to 150 million people

Satisfai Health, a leading medical solutions provider specializing in

artificial intelligence (AI) applications, particularly in Gastrointestinal

Endoscopy, has acquired an exclusive global license from the University of

Augsburg and the OTH Regensburg, Technical University of Applied Sciences, in

Germany. Satisfai will further develop AI software that will transform the

management of Barrett's Esophagus, critically the detection of early esophageal

cancer when curable. Barrett's is a gastrointestinal condition affecting around

150 million people globally. Terms of the transaction were not disclosed.

Logo - https://mma.prnewswire.com/media/1613160/Satisfai_Logo.jpg

Advanced image analysis at the point of care.

Satisfai Health's licensing of AI-enhanced software will provide clinicians

with faster, more effective diagnostics during endoscopic procedures. Diagnosis

entails imaging and biopsies of the esophagus to check for precancerous cells

(dysplasia) which can be treated to prevent esophageal cancer.

"AI will revolutionize endoscopy and our tool is the first step to improve and

optimize the detection of Barrett's cancer," said Dr. Helmut Messman, Professor

of Gastroenterology at the University of Augsburg and current President of the

European Society of Gastrointestinal Endoscopy (ESGE). "I am extremely happy

that we will continue our research in this field with Satisfai."

"OTH Regensburg and University Hospital Augsburg unite several years of

successful research in AI for the upper gastrointestinal tract," the

Universities said in a joint statement. "We are delighted to collaborate with

Satisfai to translate this research into clinical practice," said Dr Christoph

Palm, Professor of Medical Image Computing in Regensburg.

"We are passionate about developing technology that helps doctors and their

patients," stated Dr. Michael Byrne, Satisfai Health CEO, and Clinical

Professor of Medicine in Vancouver. "Our collaborations and partnerships aim to

deliver precision care to millions of patients across a range of GI diseases."

Dr James East, Associate Professor in Gastroenterology at John Radcliffe

Hospital, University of Oxford, noted, "Barrett's is the next frontier for AI

in endoscopy after the colon. Satisfai's collaboration with the Messmann group

is a giant step closer to a Barrett's AI expert at our shoulder in every

endoscopy room."

About Satisfai Health

Satisfai Health is a leading medical solutions provider specializing in AI

applications for gastroenterology.

For more information:

https://about.satisfai.health/barretts/

https://www.linkedin.com/company/satisfaihealth

Marketing | Branding | PR managed by Bammai

www.bammai.com

Contact: Andrew Stibbs

info@satisfai.health

SOURCE: Satisfai Health